TDS PDF

↑
St CLSI MR04-2019

Azithromycin Breakpoint for Neisseria gonorrhoeae. Original document CLSI MR04-2019 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI MR05-2019

Ceftaroline Breakpoints for Staphylococcus aureus. Original document CLSI MR05-2019 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI MR06-2019

Daptomycin Breakpoints for Enterococci. Original document CLSI MR06-2019 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI MR07-2020

Cefazolin Breakpoints for Enterobacterales (Systemic Infections). Original document CLSI MR07-2020 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI MR08-2020

Cefazolin Breakpoints for Enterobacterales (Uncomplicated Urinary Tract Infections). Original document CLSI MR08-2020 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI M100-2019

Performance Standards for Antimicrobial Susceptibility Testing. Original document CLSI M100-2019 in PDF full version. Additional info + preview on request

Document status: Replaced by St CLSI M100-Ed36-2026

€35
↑